OKYO Pharma Ltd is a biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
OKYO is expected to report earnings to fall 60.00% to -1 cents per share on September 02
Q2'26
Est.
$-0.02
Q4'25
Est.
$-0.05
Q3'25
Beat
by $0.02
Q2'25
Beat
by $0.02
Q1'25
Missed
by $0.01
The last earnings report on February 25 showed earnings per share of -5 cents, meeting the estimate of -5 cents. With 32.59K shares outstanding, the current market capitalization sits at 82.39M.